Despite a slower Q2, Needham sees medtech market growing 7% in 2023 (NYSE:BSX)
enot-poloskun Needham sees the medtech sector rising by 7% in 2023 versus 5.7% final yr, regardless of slowed progress in ...
Tag: NYSEBSX
enot-poloskun Needham sees the medtech sector rising by 7% in 2023 versus 5.7% final yr, regardless of slowed progress in ...
